NCT05778851 2025-10-30
ASBE
Lucid Diagnostics, Inc.
Phase NA Completed
Clinical Trials
42 trialsNCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed
NCT03366012 2024-11-08
REACT
Columbia University
Phase NA Terminated
NCT04392167 2023-11-28
a/LCI-OCT Pilot in Esophagus
Duke University
Phase NA Completed
NCT04301986 2023-05-08
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
University of North Carolina, Chapel Hill
Phase NA Completed
NCT03240679 2023-02-06
Endoscopic Mucosal Resection and Cellular Matrix
Mayo Clinic
Phase NA Terminated
NCT02560623 2022-11-17
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Mayo Clinic
Phase NA Completed
NCT03814824 2022-10-07
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
Northwell Health
Phase NA Completed
NCT02513784 2022-09-22
Mouthwash
Columbia University
Phase NA Completed
NCT03417570 2022-09-01
Cap Assisted Upper Endoscopy Versus High Definition White Light Endoscopy and Narrow Band Imaging Alone In The Detection Of Visible Lesions Barrett's Esophagus: A Randomized Tandem Study
Washington University School of Medicine
Phase NA Terminated
NCT02699060 2022-02-18
Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Its Correlation With GERD
I.M. Sechenov First Moscow State Medical University
Phase NA Completed
NCT02230410 2022-02-10
Cryoballoon
Mayo Clinic
Phase NA Completed
NCT01733147 2022-01-11
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
Mayo Clinic
Phase 4 Completed
NCT01298999 2021-11-23
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
Columbia University
Phase 2 Completed
NCT02614703 2021-08-27
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
DHR Health Institute for Research and Development
Phase 2/3 Terminated
NCT00487695 2021-06-22
CEBE
Johns Hopkins University
Phase 3 Completed
NCT02597712 2021-04-12
YF476 in Barrett's Esophagus
Trio Medicines Ltd.
Phase 2 Completed
NCT03434834 2021-04-06
OCT Pilot in Esophagus
Duke University
Phase NA Completed
NCT02106910 2020-11-20
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
University of North Carolina, Chapel Hill
Phase NA Completed
NCT01439594 2019-11-22
OFDI
Massachusetts General Hospital
Phase NA Completed
NCT02451124 2019-11-06
Non-endoscopic Brushing of the Esophagus Using a Non-endoscopic Inflatable Balloon of the Esophagus in Screening for Barrett Esophagus
Case Comprehensive Cancer Center
Phase NA Completed
NCT02395471 2019-07-30
CASEII
Medtronic - MITG
Phase NA Completed
NCT01477177 2019-05-15
Polar Wand Carbon Dioxide Cryotherapy for Barrett's Esophagus
Mayo Clinic
Phase NA Terminated
NCT02204150 2019-04-30
Study to Image the Esophagus Using the OFDI Capsule
Massachusetts General Hospital
Phase NA Completed
NCT01439633 2019-04-10
Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus
Massachusetts General Hospital
Phase NA Completed
NCT02210039 2019-04-03
Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe
Massachusetts General Hospital
Phase NA Completed
NCT02396745 2019-03-19
TECR & ECM Placement for Esophageal High Grade Dysplasia
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase NA Terminated
NCT00282672 2017-11-06
Ablation of Intestinal Metaplasia Containing Dysplasia
Medtronic - MITG
Phase NA Completed
NCT02066233 2017-07-06
Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy
Mayo Clinic
Phase NA Completed
NCT01129778 2017-06-06
Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus
Stanford University
Phase NA Terminated
NCT02162758 2017-05-11
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Takeda
Phase 2 Terminated
NCT00489268 2017-03-13
AIM
Medtronic - MITG
Phase NA Completed
NCT00795184 2016-05-03
DONTBIOPCE
Mauna Kea Technologies
Phase NA Completed
NCT01032044 2016-04-22
CLEAN-MARGIN
Mauna Kea Technologies
Phase NA Completed
NCT01093755 2016-03-17
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
Mayo Clinic
Phase 4 Completed
NCT00848237 2016-02-05
HALO Patient Registry: Ablation of Barrett's Esophagus
Medtronic - MITG
Phase NA Completed
NCT00217087 2015-12-24
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Mayo Clinic
Phase 2 Completed
NCT00754468 2015-11-04
ESODOI
CSA Medical, Inc.
Phase 4 Completed
NCT01288612 2015-01-07
challenge
Mayo Clinic
Phase NA Completed
NCT01447927 2014-07-21
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed